BCTX logo

BriaCell Therapeutics (BCTX) Net Income

Annual Net Income

-$4.79 M
+$15.51 M+76.40%

July 31, 2024

Summary

Performance

1-Year Change

+76.4%

3-Year Change

+65.32%

5-Year Change

-1.67%

15-Year Change

-85.42%

BCTX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.37%
BCTX annual net profit is higher than 78.37% of companies in Healthcare sector

High & Low

All-time High

-$8600.00

3-Year Low

-$26.84 M

Earnings dates

Last Annual Earnings Report Date

Jul 31, 2024
BCTX previous annual earnings announcement was published on Jul 31, 2024

Next Annual Earnings Report Date

N/A
BCTX next annual earnings announcement has not yet been scheduled

OtherBCTXprofitabilitymetrics:

Annual Net Margin

-
BCTX annual net profit margin value is unknown

Annual Revenue

-
BCTX annual revenue value is unknown

Annual Gross Profit

-
BCTX annual gross profit value is unknown

Annual EPS

-$4.35
BCTX annual earnings per share is -$4.35

Quarterly Net Income

-$5.80 M
-$4.59 M-377.86%

October 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

BCTX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.18%
BCTX quarterly net profit is higher than 51.18% of companies in Healthcare sector

High & Low

All-time High

$11.16 M
BCTX quarterly net profit is currently -151.99% below its historical high of $11.16 million

3-Year Low

-$11.88 M

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXprofitabilitymetrics:

Quarterly Net Margin

-
BCTX quarterly net profit margin value is unknown

Quarterly Revenue

-
BCTX quarterly revenue value is unknown

Quarterly Gross Profit

-
BCTX quarterly gross profit value is unknown

Quarterly EPS

-$3.30
BCTX quarterly earnings per share is -$3.30

TTM Net Income

-$16.60 M
-$11.80 M-246.35%

October 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

BCTX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.25%
BCTX TTM net profit is higher than 60.25% of companies in Healthcare sector

High & Low

All-time High

$1.33 M
BCTX TTM net profit is currently -1348.04% below its historical high of $1.33 million

3-Year Low

-$42.50 M

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXprofitabilitymetrics:

Annual Net Margin

-
BCTX annual net profit margin value is unknown

TTM Revenue

-
BCTX TTM revenue value is unknown

TTM Gross Profit

-
BCTX TTM gross profit value is unknown

TTM EPS

-$13.35
BCTX TTM earnings per share is -$13.35

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$4.79 M
BCTX annual net profit is -$4.79 million

Annual Revenue

-
BCTX annual revenue value is unknown

Annual Cost Of Goods Sold

-
BCTX annual cost of goods sold value is unknown

Annual Operating Expenses

$33.33 M
BCTX annual total operating expenses is $33.33 million

Annual Interest Expense

-
BCTX annual interest expense value is unknown

Annual Income Tax

-
BCTX annual income tax value is unknown

BCTX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+76.4%0.0%0.0%
3 y3 years+65.3%0.0%0.0%
5 y5 years-1.7%0.0%0.0%

BCTX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+82.2%-152.0%+51.2%-3928.0%+61.0%
5 y5-year-19.1%+82.2%-152.0%+78.9%-1348.0%+61.0%
alltimeall time<-9999.0%+82.2%-152.0%+78.9%-1348.0%+61.0%

BriaCell Therapeutics Net Income History

DateAnnualQuarterlyTTM
Oct 2024
-
-$5.80 M(+377.9%)
-$16.60 M(+246.3%)
Jul 2024
-$4.79 M(-76.4%)
-$1.21 M(-170.8%)
-$4.79 M(-20.1%)
Apr 2024
-
$1.72 M(-115.2%)
-$6.00 M(-52.4%)
Jan 2024
-
-$11.29 M(-288.2%)
-$12.61 M(-4.5%)
Oct 2023
-
$6.00 M(-348.1%)
-$13.19 M(-35.0%)
Jul 2023
-$20.30 M(-24.4%)
-$2.42 M(-50.6%)
-$20.30 M(+10.7%)
Apr 2023
-
-$4.90 M(-58.8%)
-$18.33 M(-21.8%)
Jan 2023
-
-$11.88 M(+973.8%)
-$23.45 M(+5592.8%)
Oct 2022
-
-$1.11 M(+145.7%)
-$412.00 K(-98.5%)
Jul 2022
-$26.84 M(+94.3%)
-$450.40 K(-95.5%)
-$26.84 M(-36.8%)
Apr 2022
-
-$10.02 M(-189.7%)
-$42.50 M(+43.9%)
Jan 2022
-
$11.16 M(-140.5%)
-$29.53 M(-27.8%)
Oct 2021
-
-$27.53 M(+70.9%)
-$40.93 M(+196.2%)
Jul 2021
-$13.82 M(+243.3%)
-$16.11 M(-646.1%)
-$13.82 M(-1139.0%)
Apr 2021
-
$2.95 M(-1350.4%)
$1.33 M(-162.6%)
Jan 2021
-
-$235.90 K(-44.0%)
-$2.12 M(-35.9%)
Oct 2020
-
-$421.30 K(-56.2%)
-$3.31 M(-20.0%)
Jul 2020
-$4.02 M(-14.6%)
-$962.70 K(+90.7%)
-$4.14 M(-14.6%)
Apr 2020
-
-$504.90 K(-64.6%)
-$4.85 M(-11.4%)
Jan 2020
-
-$1.42 M(+13.9%)
-$5.48 M(+4.2%)
Oct 2019
-
-$1.25 M(-25.1%)
-$5.26 M(+9.4%)
Jul 2019
-$4.71 M(+13.4%)
-$1.67 M(+47.5%)
-$4.80 M(+1.3%)
Apr 2019
-
-$1.13 M(-6.1%)
-$4.74 M(-3.2%)
Jan 2019
-
-$1.20 M(+50.9%)
-$4.90 M(+9.3%)
Oct 2018
-
-$798.40 K(-50.4%)
-$4.48 M(+7.1%)
Jul 2018
-$4.15 M(+60.8%)
-$1.61 M(+24.8%)
-$4.19 M(+13.9%)
Apr 2018
-
-$1.29 M(+63.8%)
-$3.67 M(+13.2%)
Jan 2018
-
-$787.30 K(+57.6%)
-$3.25 M(+17.0%)
Oct 2017
-
-$499.60 K(-54.5%)
-$2.77 M(+6.6%)
Jul 2017
-$2.58 M(+52.4%)
-$1.10 M(+27.5%)
-$2.60 M(+49.2%)
Apr 2017
-
-$861.00 K(+172.2%)
-$1.74 M(+42.5%)
Jan 2017
-
-$316.30 K(-3.4%)
-$1.22 M(-24.5%)
Oct 2016
-
-$327.40 K(+36.8%)
-$1.62 M(+1.2%)
Jul 2016
-$1.70 M(-36.8%)
-$239.40 K(-29.7%)
-$1.60 M(+10.3%)
Apr 2016
-
-$340.70 K(-52.3%)
-$1.45 M(-3.0%)
Jan 2016
-
-$713.60 K(+131.5%)
-$1.50 M(-46.9%)
Oct 2015
-
-$308.20 K(+244.4%)
-$2.82 M(+9.9%)
DateAnnualQuarterlyTTM
Jul 2015
-$2.68 M(-67.1%)
-$89.50 K(-76.8%)
-$2.57 M(-74.0%)
Apr 2015
-
-$385.80 K(-81.1%)
-$9.86 M(-1.5%)
Jan 2015
-
-$2.04 M(+3628.8%)
-$10.01 M(+24.3%)
Oct 2014
-
-$54.60 K(-99.3%)
-$8.05 M(-1.2%)
Jul 2014
-$8.15 M(+2109.5%)
-$7.38 M(+1271.3%)
-$8.15 M(+841.3%)
Apr 2014
-
-$538.30 K(+576.3%)
-$866.00 K(+97.6%)
Jan 2014
-
-$79.60 K(-47.6%)
-$438.30 K(-1.2%)
Oct 2013
-
-$151.80 K(+57.6%)
-$443.60 K(+19.7%)
Jul 2013
-$368.70 K(-63.0%)
-$96.30 K(-12.9%)
-$370.50 K(-51.9%)
Apr 2013
-
-$110.60 K(+30.3%)
-$769.60 K(-25.6%)
Jan 2013
-
-$84.90 K(+7.9%)
-$1.03 M(+10.2%)
Oct 2012
-
-$78.70 K(-84.1%)
-$937.90 K(-5.7%)
Jul 2012
-$995.70 K(-7.7%)
-$495.40 K(+32.2%)
-$994.30 K(-3.6%)
Apr 2012
-
-$374.80 K(-3507.3%)
-$1.03 M(+15.4%)
Jan 2012
-
$11.00 K(-108.1%)
-$893.80 K(-17.8%)
Oct 2011
-
-$135.10 K(-74.6%)
-$1.09 M(+2.7%)
Jul 2011
-$1.08 M(+19.8%)
-$532.70 K(+124.8%)
-$1.06 M(+25.3%)
Apr 2011
-
-$237.00 K(+29.4%)
-$845.70 K(-21.4%)
Jan 2011
-
-$183.20 K(+71.9%)
-$1.08 M(+14.0%)
Oct 2010
-
-$106.60 K(-66.6%)
-$943.20 K(+5.6%)
Jul 2010
-$900.70 K(+293.7%)
-$318.90 K(-31.7%)
-$893.20 K(+25.5%)
Apr 2010
-
-$466.60 K(+813.1%)
-$711.50 K(+180.4%)
Jan 2010
-
-$51.10 K(-9.7%)
-$253.70 K(+7.5%)
Oct 2009
-
-$56.60 K(-58.7%)
-$236.10 K(+3.8%)
Jul 2009
-$228.80 K(+131.3%)
-$137.20 K(+1459.1%)
-$227.40 K(+57.6%)
Apr 2009
-
-$8800.00(-73.7%)
-$144.30 K(-9.7%)
Jan 2009
-
-$33.50 K(-30.1%)
-$159.80 K(+11.7%)
Oct 2008
-
-$47.90 K(-11.5%)
-$143.00 K(+44.0%)
Jul 2008
-$98.90 K(-15.0%)
-$54.10 K(+122.6%)
-$99.30 K(+23.2%)
Apr 2008
-
-$24.30 K(+45.5%)
-$80.60 K(+23.4%)
Jan 2008
-
-$16.70 K(+297.6%)
-$65.30 K(-26.7%)
Oct 2007
-
-$4200.00(-88.1%)
-$89.10 K(-21.4%)
Jul 2007
-$116.40 K(+1253.5%)
-$35.40 K(+293.3%)
-$113.40 K(+45.4%)
Apr 2007
-
-$9000.00(-77.8%)
-$78.00 K(+13.0%)
Jan 2007
-
-$40.50 K(+42.1%)
-$69.00 K(+142.1%)
Oct 2006
-
-$28.50 K
-$28.50 K
Jul 2006
-$8600.00
-
-

FAQ

  • What is BriaCell Therapeutics annual net profit?
  • What is the all time high annual net income for BriaCell Therapeutics?
  • What is BriaCell Therapeutics annual net income year-on-year change?
  • What is BriaCell Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for BriaCell Therapeutics?
  • What is BriaCell Therapeutics quarterly net income year-on-year change?
  • What is BriaCell Therapeutics TTM net profit?
  • What is the all time high TTM net income for BriaCell Therapeutics?
  • What is BriaCell Therapeutics TTM net income year-on-year change?

What is BriaCell Therapeutics annual net profit?

The current annual net income of BCTX is -$4.79 M

What is the all time high annual net income for BriaCell Therapeutics?

BriaCell Therapeutics all-time high annual net profit is -$8600.00

What is BriaCell Therapeutics annual net income year-on-year change?

Over the past year, BCTX annual net profit has changed by +$15.51 M (+76.40%)

What is BriaCell Therapeutics quarterly net profit?

The current quarterly net income of BCTX is -$5.80 M

What is the all time high quarterly net income for BriaCell Therapeutics?

BriaCell Therapeutics all-time high quarterly net profit is $11.16 M

What is BriaCell Therapeutics quarterly net income year-on-year change?

Over the past year, BCTX quarterly net profit has changed by $0.00 (0.00%)

What is BriaCell Therapeutics TTM net profit?

The current TTM net income of BCTX is -$16.60 M

What is the all time high TTM net income for BriaCell Therapeutics?

BriaCell Therapeutics all-time high TTM net profit is $1.33 M

What is BriaCell Therapeutics TTM net income year-on-year change?

Over the past year, BCTX TTM net profit has changed by $0.00 (0.00%)